1)Matsuzawa Y:Metabolic syndrome―definition and diagnostic criteria in Japan. J Atheroscler Thromb 12:301, 2005
2)平成18年の国民健康・栄養調査結果の概要(http://www.mhlw.go.jp/houdou/2008/04/dl/h0430-2c.pdf)
3)Buchwald H, Oien DM:Metabolic/bariatric surgery Worldwide 2008. Obes Surg 19:1605-1611, 2009
4)Rubino F, Gagner M, Gentileschi P, et al:The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 240:236-242, 2004
5)Hubbard VS, Hall WH:Gastrointestinal surgery for severe obesity. Obes Surg 1:257-265, 1991
6)Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. WHO Expert Consultation. Lancet. 363:157-163, 2004
7)Lee WJ, Wang W:Bariatric surgery:Asia-Pacific perspective. Obes Surg 15:751-757, 2005
8)日本内視鏡外科学会:重症肥満に対する外科治療に対する見解.(http://www.asas.or.jp/jses/kitei/himan.html)
9)Buchwald H, Avidor Y, Braunwald E, et al:Bariatric surgery:a systematic review and meta-analysis. JAMA 292:1724-1737, 2004
10)Pories WJ, Albrecht RJ:Etiology of type Ⅱdiabetes mellitus:role of the foregut. World J Surg 25:527-531, 2001
11)Scopinaro N, Adami GF, Marinari GM, et al:Biliopancreatic diversion. World J Surg 22:936-946, 1998
12)McIntyre N, Holsworth DC, Turner DS: New interpretation of oral glucose tolerance. Lancet 2:20-21, 1964
13)La Barre J:Sur les possibilites d'un traitement du diabete par l'incretine. Bull Acad R Med Belg 12:620-634, 1932
14)Baggio LL, Drucker DJ:Biology of incretins:GLP-1 and GIP. Gastroenterology 132:2131-2157, 2007
15)Brown JC, Dryburgh JR, Ross SA, et al:Identification and actions of gastric inhibitory polypeptide. Recent Prog Horm Res 31:487-532, 1975
16)Eckel RH, Fujimoto WY, Brunzell JD:Gastric inhibitory polypeptide enhanced lipoprotein lipase activity in cultured preadipocytes. Diabetes 28:1141-1142, 1979
17)Beck B, Max JP:Gastric inhibitory polypeptide enhancement of the insulin effect on fatty acid incorporation into adipose tissue in the rat. Regul Pept 7:3-8, 1983
18)Gault VA, Irwin N, Green BD, et al:Chemical ablation of gastric inhibitory polypeptide receptor action by daily(Pro3)GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesityrelated diabetes. Diabetes 54:2436-2446, 2005
19)Mortensen K, Christensen LL, Holst JJ, et al:GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine. Regul Pept 114:189-196, 2003
20)Deacon CF, Nauck MA, Toft-Nielsen M, et al:Both subcutaneously and intravenously administered glucagon-like peptide 1 are rapidly degraded from the NH2-terminus in type Ⅱdiabetic patients and in healthy subjects. Diabetes 44:1126-1131, 1995
21)Rubino F, Gagner M:Potential of surgery for curing type 2 diabetes mellitus. Ann Surg 236:554-559, 2002
22)土屋 誉,佐々木巖,今村幹雄,他:胆道再建術の胃酸分泌および消化管ホルモン分泌に及ぼす影響に関する実験的研究.日外会誌 87:659-670,1986
23)Doi T, Naito H, Takahashi M, et al:Effect of chronic pancreatic juice diversion on enteroglucagon secretion and intestinal mucosal growth in dogs. Tohoku J Exp Med 177:279-291, 1995
24)戸田守彦,佐々木巖,内藤広郎,他:Ileo-jejunal transpositionの小腸粘膜組織像,腸管グルカゴンおよび消化吸収能に与える影響に関する実験的検討.日外会誌 91:360-372,1990
25)Ohtani N, Sasaki I, Naito H, et al:Effects of ileojejunal transposition on gastrointestinal motility, gastric emptying, and small intestinal transit in dogs. J Gastrointest Surg 3:516-523, 1999
:a report of 2 cases. Surg Obes Relat Dis 3:195-197, 2007
27)DePaula AL, Macedo AL, Rassi N, et al:Laparoscopic treatment of metabolic syndrome in patients with type 2 diabetes mellitus. Surg Endosc 22:2670-2678, 2008
28)DePaula AL, Macedo AL, Mota BR, et al:Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21-29. Surg Endosc 23:1313-1320, 2009
. Obes Surg 19:307-312, 2009
30)American Diabetes Association:Standards of medical care in diabetes―2009. Diabetes Care 32:S13-S61, 2009
31)Matsuoka K:Genetic and environmental interaction in Japanese type 2 diabetics. Diabetes Res Clin Pract 50(Suppl 2):S17-22, 2000
32)Tanaka Y, Atsumi Y, Matsuoka K, et al:Usefulness of revised Fasting plasma glucose criterion and characteristics of the insulin response to an oral glucose load in newly diagnosed Japanese diabetic subjects. Diabetes Care 21:1133-1137, 1998